Treatment of Hepatic Malignances and Disorders: The Role of Liver Bioengineering

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/978-3-319-29149-9_12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver transplantation for pediatric metabolic disease.

  2014cited by this paper
• Human-Scale Whole-Organ Bioengineering for Liver Transplantation: A Regenerative Medicine Approach

  2013cited by this paper
• Liver Support Systems: Will They Ever Reach Prime Time?

  2013cited by this paper
• Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial

  2013cited by this paper
• Use of decellularized porcine liver for engineering humanized liver organ.

  2012cited by this paper
• Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure

  2012cited by this paper
• Liver support systems--a review.

  2012cited by this paper
• Key challenges to the development of extracorporeal bioartificial liver support systems.

  2012cited by this paper
• Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.

  2012cited by this paper
• New directions for cell-based therapies in acute liver failure.

  2012cited by this paper
• Transplantation of Co-Microencapsulated Hepatocytes and HUVECs for Treatment of Fulminant Hepatic Failure

  2012cited by this paper
• Liver Anti-Fibrosis Therapy with Mesenchymal Stem Cells Secreting Hepatocyte Growth Factor

  2012cited by this paper
• Single Liver Lobe Repopulation with Wildtype Hepatocytes Using Regional Hepatic Irradiation Cures Jaundice in Gunn Rats

  2012cited by this paper
• The mouse lymph node as an ectopic transplantation site for multiple tissues

  2012cited by this paper
• Pathophysiology guided treatment of nonalcoholic steatohepatitis

  2012cited by this paper
• Mechanisms of Lipotoxicity in NAFLD and Clinical Implications

  2011cited by this paper
• Rescue of lethal hepatic failure by hepatized lymph nodes in mice.

  2011cited by this paper
• In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins

  2011cited by this paper
• Transplantation of microencapsulated umbilical-cord-blood-derived hepatic-like cells for treatment of hepatic failure.

  2011cited by this paper
• The use of whole organ decellularization for the generation of a vascularized liver organoid

  2011cited by this paper
• Adipose tissue-derived mesenchymal stem cell-based liver gene delivery.

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes

  2011cited by this paper
• Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010.

  2011cited by this paper
• Human Fatty Liver Disease: Old Questions and New Insights

  2011cited by this paper
• Interleukin-21 maintains the expression of CD16 on monocytes via the production of IL-10 by human naïve CD4+ T cells.

  2011cited by this paper
• Transplantation of Encapsulated Hepatocytes during Acute Liver Failure Improves Survival without Stimulating Native Liver Regeneration

  2011cited by this paper
• Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix.

  2011cited by this paper
• Gene therapy of liver diseases: a 2011 perspective.

  2011cited by this paper
• Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction

  2011cited by this paper
• Gene therapy for alpha-1 antitrypsin deficiency.

  2011cited by this paper
• Human Fetal Liver-Derived Stem Cell Transplantation as Supportive Modality in the Management of End-Stage Decompensated Liver Cirrhosis

  2010cited by this paper
• Harnessing RNA interference for the treatment of viral infections.

  2010cited by this paper
• Bioartificial liver support systems.

  2010cited by this paper
• Human Fetal Liver Stromal Cells That Overexpress bFGF Support Growth and Maintenance of Human Embryonic Stem Cells

  2010cited by this paper
• Barriers to the successful treatment of liver disease by hepatocyte transplantation.

  2010cited by this paper
• Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Perturbations in Ataxia Telangiectasia Mutant Signaling Pathways After Drug-Induced Acute Liver Failure and Their Reversal During Rescue of Animals by Cell Therapy

  2010cited by this paper
• Treatment of Acute Hepatic Failure in Mice by Transplantation of Mixed Microencapsulation of Rat Hepatocytes and Transgenic Human Fetal Liver Stromal Cells

  2010cited by this paper
• The etiology of hepatocellular carcinoma and consequences for treatment.

  2010cited by this paper
• Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo

  2010cited by this paper
• Autologous Hematopoietic Stem Cell Transplantation in 48 Patients with End-Stage Chronic Liver Diseases

  2010cited by this paper
• The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

  2010cited by this paper
• Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix

  2010cited by this paper
• Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes.

  2010cited by this paper
• Effects of partial liver ischemia followed by global liver reperfusion on the remote tissue expression of nitric oxide synthase: lungs and kidneys.

  2010cited by this paper
• Method for the decellularization of intact rat liver

  2010cited by this paper
• Artificial and bioartificial liver devices: present and future

  2009cited by this paper
• Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

  2009cited by this paper
• Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.

  2009cited by this paper
• Progress in bioreactors of bioartificial livers.

  2009cited by this paper
• Insulin‐like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats

  2009cited by this paper
• Maintenance of Human Hepatocyte Function In Vitro by Liver-Derived Extracellular Matrix Gels

  2009cited by this paper
• Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

  2009cited by this paper
• Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers

  2009cited by this paper
• [Surgical treatment of breast lesions: preliminary results of the screening program of the Ariana area].

  2009cited by this paper
• Coencapsulation of Hepatocytes With Bone Marrow Mesenchymal Stem Cells Improves Hepatocyte-Specific Functions

  2009cited by this paper
• Homonymous hemianopsia as the leading symptom of a tumor like demyelinating lesion: a case report

  2009cited by this paper
• The role of liver-derived insulin-like growth factor-I.

  2009cited by this paper
• Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial

  2009cited by this paper
• Extracorporeal treatment of acute liver failure

  2008cited by this paper
• Liver support devices

  2008cited by this paper
• Extracorporeal albumin dialysis

  2008cited by this paper
• Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart

  2008cited by this paper
• Artificial and bioartificial liver support.

  2008cited by this paper
• Mature Human Hepatocytes from Ex Vivo Differentiation of Alginate-Encapsulated Hepatoblasts

  2008cited by this paper
• Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis

  2008cited by this paper
• Metabolic liver disease in children

  2008cited by this paper
• Liver and Intestine Transplantation in the United States, 1997–2006

  2008cited by this paper
• Leucine stimulates HGF production by hepatic stellate cells through mTOR pathway.

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Liver and Intestine Transplantation in the United States, 1996–2005

  2007cited by this paper
• Artificial and Bioartificial Liver Support

  2007cited by this paper
• Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing

  2007cited by this paper
• Wnt and TGF-β signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells

  2006cited by this paper
• Expression of non‐signaling membrane‐anchored death receptors protects murine livers in different models of hepatitis

  2006cited by this paper
• Human hepatocyte transplantation: worldwide results.

  2006cited by this paper
• BMP-4 is required for hepatic specification of mouse embryonic stem cell–derived definitive endoderm

  2006cited by this paper
• Nonalcoholic fatty liver disease.

  2006cited by this paper
• Noninvasive evaluation of liver repopulation by transplanted hepatocytes using 31P MRS imaging in mice

  2006cited by this paper
• Engineering Complex Tissues

  2006cited by this paper
• Hepatocyte transplantation for metabolic liver disease: UK experience.

  2005cited by this paper
• Isolated Hepatocyte Transplantation for Crigler-Najjar Syndrome Type 1

  2005cited by this paper
• Efficacy and strategy of pneumatic dilatation in achalasia.

  2005cited by this paper
• Gene therapy: twenty-first century medicine.

  2005cited by this paper
• Vascular Endothelial Growth Factor-Releasing Scaffolds Enhance Vascularization and Engraftment of Hepatocytes Transplanted on Liver Lobes

  2005cited by this paper
• Bioartificial liver systems: current status and future perspective.

  2005cited by this paper
• ONE LIVER, THREE RECIPIENTS: SEGMENT IV FROM SPLIT-LIVER PROCEDURES AS A SOURCE OF HEPATOCYTES FOR CELL TRANSPLANTATION

  2004cited by this paper
• Assessing Porcine Liver-Derived Biomatrix for Hepatic Tissue Engineering

  2004cited by this paper
• Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

  2004cited by this paper
• Hepatocyte transplantation for inherited factor VII deficiency.

  2004cited by this paper
• Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up.

  2003cited by this paper
• Viral hepatitis C.

  2003cited by this paper
• Viral hepatitis B.

  2003cited by this paper
• Extracorporeal Liver Support: Waiting for the Deciding Vote

  2003cited by this paper
• Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.

  2003cited by this paper
• Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells

  2003cited by this paper
• A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor.

  2003cited by this paper
• Differential Mitogenic Effects of Single Chain Hepatocyte Growth Factor (HGF)/Scatter Factor and HGF/NK1 following Cleavage by Factor Xa*

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.

  2002cited by this paper

• No citing papers are available for this paper.